DOCSLIB.ORG

Susceptibility to Polymyxin B of Penicillin G-Induced Proteus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Susceptibility to Polymyxin B of Penicillin G-Induced Proteus JOURNAL OF BACTERIOLOGY, May 1969, p. 347-350 Vol. 98, No. 2 Copyright @ 1969 American Society for Microbiology Printed in U.S.A. Susceptibility to Polymyxin B of Penicillin G-induced Proteus mirabilis L Forms and Spheroplasts MICHAEL TEUBER Abteilung Mikrobiologie, Institut fuir Angewandte Botanik der Technischen Hochschule Miinchen, Munich, Germany Received for publication 6 January 1969 A polymyxin B-resistant strain of Proteus mirabilis was converted into L forms and spheroplasts in the presence of penicillin G. This treatment caused a 400-fold increase in polymyxin B susceptibility. The acquired susceptibility was in the range of the natural susceptibility reported for susceptible gram-negative bacteria (-1 ,ug/ml). The high susceptibility to polymyxin B was lost as soon as the spheroplasts and L forms were allowed to reconvert into the bacillary form in penicillin-free media. This behavior is strong evidence that the natural resistance of Proteus strains to polymyxins is due to the impermeability of the outer cell wall structures to these antibiotic substances. The primary mode of action of the polymyxin MATERIALS AND METHODS group antibiotics against susceptible bacteria Strain. The P. mirabilis strain used throughout seems to be a specific reaction with the cyto- this investigation was a laboratory strain from the plasmic membrane, which finally results in the collection of our department. It was classified. ac- irreversible breakdown of the permeability barrier cording to Bergey's Manual of Determinative Bac- of the cells (13, 14). It was suggested by Newton teriology. It does not have penicillinase activity. (13), on the basis of cell wall analysis of sus- Medium. The medium used contained, per liter of ceptible and resistant Pseudomonas species, that distilled water: tryptic digest of casein (Merck, in resistant bacteria the cell wall structures lo- Darmstadt, Germany), 10 g; glucose, 5 g; yeast ex- cated outside of the cytoplasmic membrane might tract (paste, Zyma Blaes, Munich, Germany) freed from insoluble material by centrifugation, 5 g; and protect this membrane from the action of poly- NaCl, 3 g; the final pH was 7.3 to 7.5. For solid myxin by their impermeability to the anti- media, 2% powdered agar-agar (Serva, Heidelberg, biotic. A direct approach to this question would Germany) was added. be the analysis of susceptible forms derived in Antibiotics. Polymyxin B sulfate (sterile powder) vitro from resistant bacteria. Proteus strains was generously supplied by Pfizer GmbH, Karlsruhe, should be suitable organisms for this kind of Germany. Penicillin G (sodium salt) was a gift from work. These organisms have an unusually high Hochst-Werke, Frankfurt/M., Germany; its specific degree of resistance against polymyxins, in activity was 1,650 units/mg. contrast to most other gram-negative bacteria, Incubation. All experiments were performed at 37 C. Liquid media were aerated by shaking on a which are very susceptible (1). In addition, reciprocal shaker (100 strokes/min). Proteus cells can be converted into spheroplasts Agar-diffusion test. An inoculum of 107 bacteria and L forms and cultivated as such in the pres- from an overnight culture was plated on solid me- ence of penicillin, a procedure altering the dium. Polymyxin B sulfate (50 ,ug in 10 Aliters of morphological and chemical properties of the water) was pipetted onto sterile filter paper discs cell wall to a high degree (2, 5, 6, 8). A detailed (diameter, 9 mm) placed in the middle of the petri analysis of stable Proteus L forms and their dishes. parent bacteria was recently published by Weibull Growth curves. Erlenmeyer flasks (100 ml) con- and co-workers (18). taining 20 ml of broth were inoculated with 0.1-ml amounts of overnight cultures of rod-shaped Proteus In this publication, I report studies which show cells or of spheroplasts. The optical density of the that P. mirabilis could, in fact, be rendered highly cultures was determined with 1-cm cells at 600 nm susceptible to polymyxin B in vitro by conversion (Fig. 1). into penicillin G-induced L forms and sphero- Growth response of spheroplasts to polymyxin B. plasts. Spheroplast cultures were grown in broth to an 347 348 TEUBER J. BACTERIOL. optical density of 0.3 at 600 nm. At this point, poly- TABLE 1. Susceptibility of Proteus mirabilis Lforms myxin B sulfate was added, and the optical density was to 50 jug ofpolymyxin B sulfate, as tested by the measured after an additional 2 hr of incubation (Fig. agar-diffusion test 2). The appearance of the cells during growth was checked with a Zeiss phase-contrast microscope. Penicillin G Zone of no growth Nomenclature. Growth in form of large, irregular- (units/ml of (mm) Shape of organisms shaped bodies is called L form, irrespective of the medium) (m)Saeoornis stability of the cells possessing this property. Regular- shaped, round bodies are called spheroplasts. 0 0 rods 1 1 elongated, swollen RESULTS rods 2.5 15 i 2 L forms Conditions for the formation of penicillin- 5.0 15 i 2 L forms induced L forms and spheroplasts. On solid medium, growth of L-form colonies was ob- tained at a penicillin G concentration of 2.5 penicillin levels. Microscopic examination of units/ml. In a typical experiment, from 107 these colonies revealed that all of them were of rod-shaped bacteria plated, about 103 L-phase the intermediate growth type. When 20 selected colonies developed at 2.5 units of penicillin G/ml L-phase colonies grown on penicillin-containing and about 102 at 5 units/ml. Higher concentra- plates (2.5 units/ml) were transferred to a penicil- tions of penicillin were less favorable. The colo- lin-free medium, they regained a bacillary appear- nies were 1 to 2 mm in diameter after 48 hr of ance and their polymyxin resistance ( > 50,gg/ml), incubation. Usually, no rod-shaped bacteria whereas transfer to a penicillin-containing medium grew under these conditions. On the other hand, preserved the high polymyxin susceptibility to- 1 unit of penicillin/ml was not sufficient to induce gether with L-form growth. From these results, it L forms. Microscopic examination showed is clear that the penicillin-induced changes in the elongated rods swollen at the region of cell divi- cell wall have to be severe enough to allow L- sion. The L forms could be converted back to a form growth in order to produce full suscepti- bacillary type of growth by a single transfer to bility to polymyxin B. Since a quantitative evalua- the penicillin-free medium, as checked with 20 tion with polymyxin is difficult to do by the agar randomly selected L-phase colonies. plate diffusion test (because of the low diffusion In liquid culture at a penicillin G concentra- rate of polymyxin), further experiments were tion of 2.5 units/ml, L forms isolated from performed with liquid cultures. penicillin-containing plates could be cultivated in As judged turbidimetrically (Fig. 1), addition the form of spheroplasts with a doubling time of polymyxin B sulfate to logarithmically growing of 78 min, as compared with 42 min for the penicillin spheroplasts of P. mirabilis in broth parent bacillary form in penicillin-free medium. resulted in complete and immediate cessation of Doubling time was defined as the time needed to growth. The parent bacillary form, however, was allow doubling of the optical density during the only slightly affected by the same doses of poly- linear part of the growth curve (see Fig. 1). myxin B sulfate (5 and 50 ,ug/ml). The drop in the Continuous microscopic examination during the optical density of the spheroplast culture ob- growth cycle revealed only spheroplasts, but no served after polymyxin application was caused by rods. a macroscopically and microscopically visible The unusually low penicillin concentration aggregation of the spheroplasts to clumps con- necessary to induce L forms and spheroplasts is taining up to several hundred organisms. This ob- a particular property of the P. mirabilis strain servation is in accordance with the report by used. Latterrade and Macheboeuf (7) that rough forms Susceptibility to polymyxin B sulfate of L of gram-negative bacteria are agglutinated by forms and spheroplasts. From the data presented polymyxin. Extensive lysis could be excluded be- in Table 1, it appears that penicillin-induced L cause only very few ghosts were detected under forms of P. mirabilis are susceptible to concentra- the microscope. In Fig. 2, results are presented tions of polymyxin B sulfate to which the rod- which indicate that as little as 0.1 ,ug of polymyxin shaped parent form is totally resistant. The in- B sulfate per ml had a significantly inhibitory termediate form (elongated, swollen rods) growing effect on growing penicillin spheroplasts of P. at the low penicillin G concentration (1 unit/ml) mirabilis. The minimal concentration required to seems to be almost as resistant as the true rod- halt growth completely under the conditions em- shaped form. Occasionally, and mainly after pro- ployed was calculated from these data to be 1.6 longed incubation, a few colonies developed ,ug of polymyxin B sulfate/ml. For a 50% reduc- within the zone of inhibition at the two higher tion of the growth rate, 0.2 ,ug/ml was sufficient. VOL. 98, 1969 POLYMYXIN-SUSCEPTIBLE SPHEROPLASTS OF PROTEUS 349 tibility of the P. mirabilis spheroplasts was de- termined to be 400-fold. In conclusion, it can be 5 0 °50 stated that P. mirabilis spheroplasts are at least as - 2.0 ROD susceptible to polymyxin B as most of the other E 'L gram-negative bacteria which are sensitive a 0 0 priori (for a comparison, see 14). co 1.0 L IW 1-. I,/I DISCUSSION ,'( Since polypeptide antibiotics of the polymyxin >.
Load more

Recommended publications
  • Gram-Negative Bacteria; for Instance, Coetzee Spheroplast Formation
    Agric. Biol. Chem., 49 (1), 133-140, 1985 133 Fusion of Spheroplasts and Genetic Recombination of Zymomonasmobilis Hideshi Yanase, Masaru Yasui, Takayuki Miyazaki and KenzoTonomura Department of Agricultural Chemistry, College of Agriculture, University of Osaka Prefecture, Mozu-ume-machi, Sakai, Osaka 591, Japan Received July 1.8, 1984 Spheroplasts of Zymomonasmobilis (Z-6) were prepared by cultivating it in a hypertonic mediumcontaining penicillin G or glycine at 30°C for more than 6 hr. Thereversion of spheroplasts to a bacillary form was observed at frequencies of 10~2 to 10~3 whenspheroplasts were incubated on hypertonic solid agar plates overlaid with soft agar. Spheroplast fusion was attempted with polyethylene glycol 6000 by crossing two mutants lacking the ability to ferment sugars. Fusants were selected, and obtained at high frequencies. The properties of a stable fusant are discussed. Recently broad host-range plasmids have Media. For the cultivation of Zymomonasstrains, RM and T media were used. RMmediumcontained 2% been transferred into Zymomonasmobilis by glucose, 1.0% yeast extract and 0.2% KH2PO4, pH 6.0. T conjugation.1 ~4) However, transformation medium contained 10% glucose, 1% yeast extract, 1% and transduction have not yet been accom- KH2PO4, 1% (NH4)2SO4 and 0.05% MgSO4-7H2O, pH plished. Besides, cell fusion could be regarded 5.6. For the formation of spheroplasts, S mediumwas used as a useful method for strain improvement. containing 20%sucrose, 2%glucose, 1%yeast extract, There have been manyreports indicating pro- 0.2% KH2PO4 and 0.2% MgSO4à"7H2O, pH 6.0. For the toplast fusion in Gram-positive bacteria such regeneration, R mediumwas used containing 16% sor- as Bacillus^ Staphylococcus,6) Brevibacte- bitol, 2% glucose, 1% yeast extract and 0.2% KH2PO4, pH riurn1) and Streptomyces^ but only a few on Gram-negative bacteria; for instance, Coetzee Spheroplast formation.
    [Show full text]
  • Activity of Cefepime-Zidebactam Against Multidrug-Resistant (MDR) Gram-Negative Pathogens
    antibiotics Article Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens Kenneth S. Thomson 1,* , Sameh AbdelGhani 1,2, James W. Snyder 1 and Gina K. Thomson 1,3 1 Department of Pathology and Laboratory Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA; [email protected] (S.A.); [email protected] (J.W.S.); [email protected] (G.K.T.) 2 Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt 3 Microbiology Department, University of Louisville Hospital, Louisville, KY 40202, USA * Correspondence: [email protected] Received: 18 February 2019; Accepted: 19 March 2019; Published: 23 March 2019 Abstract: This study compared the activity of cefepime + zidebactam (FEP-ZID) and selected currently available antibacterial agents against a panel of multidrug-resistant (MDR) clinical isolates chosen to provide an extreme challenge for antibacterial activity. FEP–ZID had a very broad and potent in vitro spectrum of activity, and was highly active against many MDR isolates of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii. Notably, it inhibited isolates producing carbapenemases of Ambler classes A, B, and D, and P. aeruginosa isolates with multiple resistance mechanisms including combinations of upregulated efflux, diminished or non-functional OprD porins, and AmpC overproduction. Its clinical role will be determined initially by the breakpoints assigned to it, comparison studies with other investigational β-lactamase inhibitor combinations, and ultimately by the developing body of therapeutic outcome data. Keywords: carbapenemase-producing organism; carbapenemase; zidebactam; therapy 1. Introduction Gram-negative multidrug-resistant (MDR) pathogens, particularly carbapenemase-producing organisms (CPOs), cause infections of high mortality that are typically treated with antibiotic combinations that include toxic drugs such as polymyxins and aminoglycosides [1].
    [Show full text]
  • Distinct Single-Cell Morphological Dynamics Under Beta-Lactam Antibiotics
    Molecular Cell Article Distinct Single-Cell Morphological Dynamics under Beta-Lactam Antibiotics Zhizhong Yao,1,3 Daniel Kahne,1,4,* and Roy Kishony2,3,* 1Department of Chemistry and Chemical Biology 2School of Engineering and Applied Sciences Harvard University, 12 Oxford Street, Cambridge, MA 02138, USA 3Department of Systems Biology 4Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA *Correspondence: [email protected] (D.K.), [email protected] (R.K.) http://dx.doi.org/10.1016/j.molcel.2012.09.016 SUMMARY in cell division, elongation, and shape maintenance (Spratt, 1975). It has been proposed that inhibition of crosslink forma- The bacterial cell wall is conserved in prokaryotes, tion by beta-lactams combined with misregulated cell-wall stabilizing cells against osmotic stress. Beta- degradation by PG hydrolases results in the accumulation of lactams inhibit cell-wall synthesis and induce lysis PG defects, which ultimately leads to cell lysis (Chung et al., through a bulge-mediated mechanism; however, 2009). little is known about the formation dynamics and The physical process of PG defect formation and subsequent stability of these bulges. To capture processes of lysis is poorly understood. Previous literature suggested a bulge-mediated process (Chung et al., 2009; Huang et al., different timescales, we developed an imaging 2008), and the reported rates of lysis have been loosely charac- platform combining automated image analysis with terized as slow and fast (de Pedro et al., 2002). However, in the live-cell microscopy at high time resolution. Beta- absence of systematic characterization of bulge-formation lactam killing of Escherichia coli cells proceeded dynamics and their variability across individual cells, it is unclear through four stages: elongation, bulge formation, whether lysis occurs uniformly within isogenic cell populations, bulge stagnation, and lysis.
    [Show full text]
  • Antibiotic Use Guidelines for Companion Animal Practice (2Nd Edition) Iii
    ii Antibiotic Use Guidelines for Companion Animal Practice (2nd edition) iii Antibiotic Use Guidelines for Companion Animal Practice, 2nd edition Publisher: Companion Animal Group, Danish Veterinary Association, Peter Bangs Vej 30, 2000 Frederiksberg Authors of the guidelines: Lisbeth Rem Jessen (University of Copenhagen) Peter Damborg (University of Copenhagen) Anette Spohr (Evidensia Faxe Animal Hospital) Sandra Goericke-Pesch (University of Veterinary Medicine, Hannover) Rebecca Langhorn (University of Copenhagen) Geoffrey Houser (University of Copenhagen) Jakob Willesen (University of Copenhagen) Mette Schjærff (University of Copenhagen) Thomas Eriksen (University of Copenhagen) Tina Møller Sørensen (University of Copenhagen) Vibeke Frøkjær Jensen (DTU-VET) Flemming Obling (Greve) Luca Guardabassi (University of Copenhagen) Reproduction of extracts from these guidelines is only permitted in accordance with the agreement between the Ministry of Education and Copy-Dan. Danish copyright law restricts all other use without written permission of the publisher. Exception is granted for short excerpts for review purposes. iv Foreword The first edition of the Antibiotic Use Guidelines for Companion Animal Practice was published in autumn of 2012. The aim of the guidelines was to prevent increased antibiotic resistance. A questionnaire circulated to Danish veterinarians in 2015 (Jessen et al., DVT 10, 2016) indicated that the guidelines were well received, and particularly that active users had followed the recommendations. Despite a positive reception and the results of this survey, the actual quantity of antibiotics used is probably a better indicator of the effect of the first guidelines. Chapter two of these updated guidelines therefore details the pattern of developments in antibiotic use, as reported in DANMAP 2016 (www.danmap.org).
    [Show full text]
  • Swedres-Svarm 2010
    SVARM|2010 Swedish Veterinary Antimicrobial Resistance Monitoring Content Swedish Veterinary Antimicrobial Resistance Monitoring 2010 Preface .............................................................................................3 Guidance for readers ........................................................................4 Editors Summary ..........................................................................................5 Björn Bengtsson, Helle Ericsson Unnerstad, Sammanfattning...............................................................................7 Christina Greko, Ulrika Grönlund Andersson and Annica Landén Use of antimicrobials .......................................................................9 Department of Animal Health and Zoonotic bacteria ...........................................................................14 Antimicrobial Strategies, National Veterinary Salmonella ...................................................................................14 Institute (SVA) SE-751 89 Uppsala, Sweden Campylobacter .............................................................................18 Methicillin resistant Staphylococcus aureus (MRSA) ....................19 Authors Highlight: Escherichia coli with ESBL - or transferrable Björn Bengtsson, Helle Ericsson Unnerstad, AmpC-type resistance in broilers .............................................22 Christina Greko, Ulrika Grönlund Andersson and Annica Landén Indicator bacteria ...........................................................................24
    [Show full text]
  • Neomycin and Polymyxin B Sulfates and Gramicidin
    NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN- neomycin sulfate, polymyxin b sulfate and gramicidin solution/ drops A-S Medication Solutions ---------- Neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution, USP (Sterile) Rx only DESCRIPTION: Neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution, USP is a sterile antimicrobial solution for ophthalmic use. Each mL contains: ACTIVES: Neomycin Sulfate, (equivalent to 1.75 mg neomycin base), Polymyxin B Sulfate equal to 10,000 Polymyxin B units, Gramicidin, 0.025 mg; INACTIVES: Sodium Chloride, Alcohol (0.5%), Poloxamer 188, Propylene Glycol, Purified Water. Hydrochloric Acid and/ or Ammonium Hydroxide may be added to adjust pH (4.7-6.0). PRESERVATIVE ADDED: Thimerosal 0.001%. Neomycin Sulfate is the sulfate salt of neomycin B and C, which are produced by the growth of Streptomyces fradiae Waksman (Fam. Streptomycetaceae). It has a potency equivalent of not less than 600 micrograms of neomycin base per milligram, calculated on an anhydrous basis. The structural formulae are: Polymyxin B Sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per milligram, calculated on an anhydrous basis. The structural formulae are: Gramicidin (also called gramicidin D) is a mixture of three pairs of antibacterial substances (Gramicidin A, B and C) produced by the growth of Bacillus brevis Dubos (Fam. Bacillaceae). It has a potency of not less than 900 mcg of standard gramicidin per mg. The structural formulae are: CLINICAL PHARMACOLOGY: A wide range of antibacterial action is provided by the overlapping spectra of neomycin, polymyxin B sulfate, and gramicidin.
    [Show full text]
  • The Effect of Spheroplast Formation on the Transformation Efficiency in Escherichia Coli Dh5α IRIS LIU, MARTHA LIU, KAREN SHERGILL Microbiology and Immunology, UBC
    Journal of Experimental Microbiology and Immunology (JEMI) Vol. 9:81-85 Copyright © April 2006, M&I, UBC The Effect of Spheroplast Formation on the Transformation Efficiency in Escherichia coli DH5α IRIS LIU, MARTHA LIU, KAREN SHERGILL Microbiology and Immunology, UBC Based on the observation that transformation in Escherichia coli is an inefficient process, it was hypothesized that transformation may be hindered by the presence of the outer membrane and the cell wall. To test this hypothesis, cells which lack both a cell wall and most of its outer membrane, termed spheroplasts, were created and transformed with pUC8 plasmid. Spheroplast formation was induced by incubating exponentially growing E. coli DH5α in ampicillin and sucrose. To transform these spheroplasts, the cells were subjected to a modified version of the Hanahan protocol, which involves treating the cells with calcium chloride. The results of this experiment suggest that spheroplasts can transform at 4.9 × 10-4. This is 100 fold more efficient than using the modified Hanahan protocol on wildtype E. coli DH5α cells. ________________________________________________________________ Competence is the ability of a bacterium to take up and physical aspects of the outer membrane hinders foreign DNA from the environment and the DNA uptake. If this is true, then removing the outer recombination or incorporation of this DNA is known membrane should increase transformation efficiency. as transformation (14). Although Escherichia coli is In the past, many groups have created strains of E. not considered to be a naturally competent organism, coli, such as ML-308, which have lost most their cell competence can be developed through various wall and only have remnants of an outer membrane (1, procedures.
    [Show full text]
  • Automated Image Analysis for Quantification of Filamentous Bacteria
    Syddansk Universitet Automated image analysis for quantification of filamentous bacteria Fredborg, M.; Rosenvinge, Flemming Schønning; Spillum, E.; Kroghsbo, S.; Wang, M.; Søndergaard, Teis Esben Published in: B M C Microbiology DOI: 10.1186/s12866-015-0583-5 Publication date: 2015 Document version Publisher's PDF, also known as Version of record Document license CC BY Citation for pulished version (APA): Fredborg, M., Rosenvinge, F. S., Spillum, E., Kroghsbo, S., Wang, M., & Sondergaard, T. E. (2015). Automated image analysis for quantification of filamentous bacteria. B M C Microbiology, 15, [255]. DOI: 10.1186/s12866- 015-0583-5 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 09. Sep. 2018 Fredborg et al. BMC Microbiology (2015) 15:255 DOI 10.1186/s12866-015-0583-5 METHODOLOGY ARTICLE Open Access Automated image analysis for quantification of filamentous bacteria Marlene Fredborg1,4*, Flemming S.
    [Show full text]
  • Conjunctivitis Or Worse?
    Red Eye in Dogs and CatS: Conjunctivitis or Worse? Tracy Revoir, DVM Senior Manager of Veterinary Support, Dechra Veterinary Products It should come as no surprise that conjunctivitis is Common Causes of Conjunctivitis the most common ophthalmic disorder in dogs and cats. But because the clinical signs of conjunctivitis If you do confirm conjunctivitis, the next step is can mimic those of more serious ophthalmic identifying the cause. If both eyes are affected and diseases (glaucoma and uveitis), it’s important to abnormal clinical signs are apparent in other body confirm your diagnosis. systems, think underlying systemic disease. If only one eye is affected, rule out infection, tear film What are important clues to the severity of the deficiencies, an irritant, anatomical abnormality, condition? With conjunctivitis, the inflammation or deeper ocular disease. should be limited to the conjunctiva. Hyperemic conjunctival vessels are superficial, branching, In dogs, conjunctivitis can result from anatomical and bright red. They are movable over the deeper disorders, irritants, infection (usually bacterial), or episcleral vessels and can be blanched with topical atopy. Most bacterial infections are secondary dilute phenylephrine. With glaucoma and uveitis, the conditions, most often to allergies. In cats, herpes- episcleral vessels are engorged; they are dark red, virus and Chlamydophila felis are the most common deep, straight, and immobile and do not blanch with causes of conjunctivitis. Atopy can also be topical dilute phenylephrine. With conjunctivitis, an issue in cats. the Schirmer tear test and intraocular pressures are normal. And the cornea should be clear and no aqueous flare should be present. The pupil and Addressing the Problem pupillary responses are normal and intraocular structures should be visible.
    [Show full text]
  • Polymyxin B & Colistin Dosing Tip Sheet
    Stanford Antimicrobial Safety & Sustainability Program Polymyxin B & Colistin Dosing Tip Sheet What: Polymyxin B is preferred over Colistin (polymyxin E) for infections due to multidrug resistant gram- negative bacilli at Stanford Health Care. SHC formulary restriction criteria – Polymyxin B 1. Infectious Disease Consultation and ID recommendation for use 2. Cystic Fibrosis team SHC formulary restriction criteria – Colistin 1. Treatment of urinary tract infections 2. Inhalation route Why: Polymyxin B and Colistin have the same spectrum of activity. However, Polymyxin B has favorable clinical pharmacologic properties compared to Colistin o Polymyxin B is an active drug, whereas Colistin is administered as the prodrug colistimethate sodium (CMS) and has variable and slow (hours) conversion to the active moiety o Polymyxin B may be less nephrotoxic How: Polymyxin B and Colistin dosing is NOT interchangeable o Polymyxin B is usually dosed by “unit”, not “mg” o Note that with Polymyxin B, each 500,000 units is diluted in 300-500mL: a typical dose may result in 1L of fluid o Consult ID pharmacists if MIC ≥ 2 for alternative dosing strategies Dosing 50-79 30-49 10-29 IHD Route ≥80 mL/min mL/min mL/min mL/min CRRT Polymyxin B No Data; Use actual body IV 7,500 – 12,500 units/kg Q12H Consult ID weight; adjusted body wt for obese pharmacist 2.5 mg/kg 1.5 mg/kg 5 mg/kg/day 1.25–1.9 mg/kg Q24H 1.5 mg/kg Q24-48h Colistin IV in 2-3 divided -OR- Use ideal body Q12H Q36H 2.5 mg/kg weight doses 1.25 mg/kg Q12h Q12-24H Doses expressed in colistin base activity Inhalation 150 mg inhalation Q12H Conversions: Colistimethate sodium 1 mg = ~12,500 units of colistimethate sodium Colistimethate sodium ~2.67 mg = 1 mg of colistin base activity 1 mg colistin base activity (CBA) = 30,000 IU colistin 1 mg polymyxin B = 10,000 IU polymyxin B Orig date: 2/23/2015 LM, EM Stanford Antimicrobial Safety & Sustainability Program References: Micromedex online, accessed 2/17/2016 Nelson, Brian C., et al.
    [Show full text]
  • Farrukh Javaid Malik
    I Farrukh Javaid Malik THESIS PRESENTED TO OBTAIN THE GRADE OF DOCTOR OF THE UNIVERSITY OF BORDEAUX Doctoral School, SP2: Society, Politic, Public Health Specialization Pharmacoepidemiology and Pharmacovigilance By Farrukh Javaid Malik “Analysis of the medicines panorama in Pakistan – The case of antimicrobials: market offer width and consumption.” Under the direction of Prof. Dr. Albert FIGUERAS Defense Date: 28th November 2019 Members of Jury M. Francesco SALVO, Maître de conférences des universités – praticien hospitalier, President Université de Bordeaux M. Albert FIGUERAS, Professeur des universités – praticien hospitalier, Director Université Autonome de Barcelone Mme Antonia AGUSTI, Professeure, Vall dʹHebron University Hospital Referee Mme Montserrat BOSCH, Praticienne hospitalière, Vall dʹHebron University Hospital Referee II Abstract A country’s medicines market is an indicator of its healthcare system, the epidemiological profile, and the prevalent practices therein. It is not only the first logical step to study the characteristics of medicines authorized for marketing, but also a requisite to set up a pharmacovigilance system, thus promoting rational drug utilization. The three medicines market studies presented in the present document were conducted in Pakistan with the aim of describing the characteristics of the pharmaceutical products available in the country as well as their consumption at a national level, with a special focus on antimicrobials. The most important cause of antimicrobial resistance is the inappropriate consumption of antimicrobials. The results of the researches conducted in Pakistan showed some market deficiencies which could be addressed as part of the national antimicrobial stewardship programmes. III Résumé Le marché du médicament d’un pays est un indicateur de son système de santé, de son profil épidémiologique et des pratiques [de prescription] qui y règnent.
    [Show full text]
  • Belgian Veterinary Surveillance of Antibacterial Consumption National
    Belgian Veterinary Surveillance of Antibacterial Consumption National consumption report 2020 Publication : 22 June 2021 1 SUMMARY This annual BelVet-SAC report is now published for the 12th time and describes the antimicrobial use (AMU) in animals in Belgium in 2020 and the evolution since 2011. For the third year this report combines sales data (collected at the level of the wholesalers-distributors and the compound feed producers) and usage data (collected at farm level). This allows to dig deeper into AMU at species and farm level in Belgium. With a consumption of 87,6 mg antibacterial compounds/kg biomass an increase of +0.2% is seen in 2020 in comparison to 2019. The increase seen in 2020 is spread over both pharmaceuticals (+0.2%) and antibacterial premixes (+4.0%). This unfortunately marks the end of a successful reduction in antibacterial product sales that was seen over the last 6 years resulting in a cumulative reduction of -40,2% since 2011. The gap seen in the coverage of the sales data with the Sanitel-Med collected usage data increased substantially compared to 2019, meaning continuous efforts need to be taken to ensure completeness of the collected usage data. When looking at the evolution in the number of treatment days (BD100) at the species level, as calculated from the SANITEL- MED use data, use increased in poultry (+5,0%) and veal calves (+1,9%), while it decreased in pigs (-3,1%). However, the numerator data for this indicator remain to be updated for 2020, potentially influencing the reliability of the result.
    [Show full text]